Updated Jul 16, 2026
Prener Anne has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the SEC filing context provided (Keros Therapeutics, Inc., with the most recent filing date 2026-07-06), a person named Prener Anne is associated with Keros Therapeutics. There is no readily available public biographical profile or detailed background information for this exact name in widely accessible sources. Therefore, the publicly verifiable biography is limited to the administrative context that this individual appears in relation to the company; the exact role, background, and career history are not confirmed in the available data. Verification from the SEC filing itself or the company’s investor relations materials would be required for a definitive biography.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | KROS | Keros Therapeutics, Inc. | A — Grant or award | 13.8K | $0.00 |
Based on the SEC filing context provided (Keros Therapeutics, Inc., with the most recent filing date 2026-07-06), a person named Prener Anne is associated with Keros Therapeutics. There is no readily available public biographical profile or detailed background information for this exact name in widely accessible sources. Therefore, the publicly verifiable biography is limited t…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Prener Anne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.